Inhibition of TRPM8 led to downmodulation of Wnt pathway transcription and increased expression of oncogenes (C-Myc and Cylin D1) and β-catenin, suggesting a potential treatment target in CRC (Pagano et al., 2023). The gene discussed is MYC; the disease is colorectal carcinoma.